BASF has received approval from the Therapeutic Goods Administration (TGA) in Australia to supply a human milk oligosaccharide ingredient, 2’Fucosyllactose (2’-FL), for use as a prebiotic in dietary supplements in Australia.
Researchers are proposing to fortify food categories such as bread, biscuits, noodles, fat spreads, sauces and palm oil with plant sterols, as a measure to reduce risk factors associated with heart diseases among the Indonesian population.
BASF is conducting a clinical trial amongst Malaysia’s university athletes with its peptide ingredient that was developed via artificial intelligence (AI).